软弱和子宫内膜癌患者的生存:一个元分析
1Oncology Ward 1, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, China.
Research in nursing & health
|March 11, 2025
概括
脆弱性显著恶化了子宫内膜癌 (EC) 妇女的生存结果. 这项元分析表明,脆弱的EC患者的整体存活率 (OS) 和无进展存活率 (PFS) 较差,突出了风险分层的脆弱性评估.
科学领域:
- 在瘤学瘤学.
- 老年病的医生 老年病的医生
- 流行病学 流行病学
背景情况:
- 脆弱是癌症患者结果的公认预测因素.
- 软弱对子宫内膜癌 (EC) 患者的存活率的影响尚未得到充分证实.
- 子宫内膜癌是全球妇女的重大健康问题.
研究的目的:
- 调查脆弱性和整体存活率 (OS) 之间的关联.
- 检查脆弱性和无进展生存期 (PFS) 之间的关系.
- 评估软弱作为子宫内膜癌患者的预后因素.
主要方法:
- 对队列研究进行系统审查和元分析.
- 在PubMed,Embase和Web of Science数据库中搜索到2024年9月28日.
- 包括在内的研究报告了脆弱与非脆弱EC患者的OS或PFS危险比率 (HRs);使用随机效应模型.
主要成果:
- 八项研究 (486,138名女性) 发现虚弱与糟糕的生存状况相关 (HR: 1.78,95% CI: 1.56-2.03,p<0.001).
- 四项研究 (378名女性) 发现虚弱与PFS恶化相关 (HR: 1.91,95% CI: 1.24-2.95,p=0.003).
- 在OS或PFS分析中没有观察到显著的异质性 (I2=0%).
结论:
- 软弱与子宫内膜癌患者的整体存活率较差和无进展存活率显著相关.
- 脆弱性评估可能在EC患者的风险分层和预后预测中发挥作用.
- 这些发现需要在大型前性队列研究中进行验证.
相关概念视频
01:24Kaplan-Meier Approach
74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74
01:15Assumptions of Survival Analysis
83
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
83
01:20Comparing the Survival Analysis of Two or More Groups
115
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
115
01:21Cancer Survival Analysis
318
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
318